Influenza

Partnership Contribution Collection

Amounts to be paid by individual manufacturers are based on principles of transparency and equity, and take into account the manufacturers' nature and capacities (see PIP Framework, section 6.14.3). The Framework defines "influenza vaccine, diagnostic and pharmaceutical manufacturers" as:

  • public or private entities including academic institutions, government owned or government subsidized entities, non-profit organizations or commercial entities;
  • which develop and/or produce human influenza vaccines or other products derived from or using H5N1 or other influenza viruses of human pandemic potential" (see Framework, section 4.3).

The PIP Secretariat uses a set of standard operating procedures (SOPs) to identify manufacturers using GISRS and divide up the payment of the PC among companies. The SOPs were developed in line with the WHO document on Distribution of Partnership Contribution among Companies.

Collection Results

2015

2014

2013

Reference Documents